Evolving treatment strategies for myeloma

In this article, we will discuss how treatment strategies for myeloma have evolved and outline the challenges now faced following the introduction of a number of novel active agents. In particular, we will focus on how achieving a maximum response and maintaining such responses is becoming a key the...

Descripción completa

Detalles Bibliográficos
Autores principales: Morgan, G J, Davies, F E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361851/
https://www.ncbi.nlm.nih.gov/pubmed/15655538
http://dx.doi.org/10.1038/sj.bjc.6602341
_version_ 1782153315593748480
author Morgan, G J
Davies, F E
author_facet Morgan, G J
Davies, F E
author_sort Morgan, G J
collection PubMed
description In this article, we will discuss how treatment strategies for myeloma have evolved and outline the challenges now faced following the introduction of a number of novel active agents. In particular, we will focus on how achieving a maximum response and maintaining such responses is becoming a key therapeutic strategy and how novel agents can be used to achieve this in the context of current strategies such as autologous transplantation.
format Text
id pubmed-2361851
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23618512009-09-10 Evolving treatment strategies for myeloma Morgan, G J Davies, F E Br J Cancer Minireview In this article, we will discuss how treatment strategies for myeloma have evolved and outline the challenges now faced following the introduction of a number of novel active agents. In particular, we will focus on how achieving a maximum response and maintaining such responses is becoming a key therapeutic strategy and how novel agents can be used to achieve this in the context of current strategies such as autologous transplantation. Nature Publishing Group 2005-01-31 2005-01-18 /pmc/articles/PMC2361851/ /pubmed/15655538 http://dx.doi.org/10.1038/sj.bjc.6602341 Text en Copyright © 2005 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Minireview
Morgan, G J
Davies, F E
Evolving treatment strategies for myeloma
title Evolving treatment strategies for myeloma
title_full Evolving treatment strategies for myeloma
title_fullStr Evolving treatment strategies for myeloma
title_full_unstemmed Evolving treatment strategies for myeloma
title_short Evolving treatment strategies for myeloma
title_sort evolving treatment strategies for myeloma
topic Minireview
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361851/
https://www.ncbi.nlm.nih.gov/pubmed/15655538
http://dx.doi.org/10.1038/sj.bjc.6602341
work_keys_str_mv AT morgangj evolvingtreatmentstrategiesformyeloma
AT daviesfe evolvingtreatmentstrategiesformyeloma

Ejemplares similares